Cargando…

Disinvestment policy and the public funding of assisted reproductive technologies: outcomes of deliberative engagements with three key stakeholder groups

BACKGROUND: Measures to improve the quality and sustainability of healthcare practice and provision have become a policy concern. In addition, the involvement of stakeholders in health policy decision-making has been advocated, as complex questions arise around the structure of funding arrangements...

Descripción completa

Detalles Bibliográficos
Autores principales: Hodgetts, Katherine, Hiller, Janet E, Street, Jackie M, Carter, Drew, Braunack-Mayer, Annette J, Watt, Amber M, Moss, John R, Elshaug, Adam G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4016640/
https://www.ncbi.nlm.nih.gov/pubmed/24885716
http://dx.doi.org/10.1186/1472-6963-14-204
_version_ 1782315539895418880
author Hodgetts, Katherine
Hiller, Janet E
Street, Jackie M
Carter, Drew
Braunack-Mayer, Annette J
Watt, Amber M
Moss, John R
Elshaug, Adam G
author_facet Hodgetts, Katherine
Hiller, Janet E
Street, Jackie M
Carter, Drew
Braunack-Mayer, Annette J
Watt, Amber M
Moss, John R
Elshaug, Adam G
author_sort Hodgetts, Katherine
collection PubMed
description BACKGROUND: Measures to improve the quality and sustainability of healthcare practice and provision have become a policy concern. In addition, the involvement of stakeholders in health policy decision-making has been advocated, as complex questions arise around the structure of funding arrangements in a context of limited resources. Using a case study of assisted reproductive technologies (ART), deliberative engagements with a range of stakeholder groups were held on the topic of how best to structure the distribution of Australian public funding in this domain. METHODS: Deliberative engagements were carried out with groups of ART consumers, clinicians and community members. The forums were informed by a systematic review of ART treatment safety and effectiveness (focusing, in particular, on maternal age and number of treatment cycles), as well as by international policy comparisons, and ethical and cost analyses. Forum discussions were transcribed and subject to thematic analysis. RESULTS: Each forum demonstrated stakeholders’ capacity to understand concepts of choice under resource scarcity and disinvestment, and to countenance options for ART funding not always aligned with their interests. Deliberations in each engagement identified concerns around ‘equity’ and ‘patient responsibility’, culminating in a broad preference for (potential) ART subsidy restrictions to be based upon individual factors rather than maternal age or number of treatment cycles. Community participants were open to restrictions based upon measures of body mass index (BMI) and smoking status, while consumers and clinicians saw support to improve these factors as part of an ART treatment program, as distinct from a funding criterion. All groups advocated continued patient co-payments, with measures in place to provide treatment access to those unable to pay (namely, equity of access). CONCLUSIONS: Deliberations yielded qualitative, socially-negotiated evidence required to inform ethical, accountable policy decisions in the specific area of ART and health care more broadly. Notably, reductionist, deterministic characterizations of stakeholder ‘self-interest’ proved unfounded as each group sought to prioritise universal values (in particular, ‘equity’ and ‘responsibility’) over specific, within-group concerns. Our results - from an emotive case study in ART - highlight that evidence-informed disinvestment decision-making is feasible, and potentially less controversial than often presumed.
format Online
Article
Text
id pubmed-4016640
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40166402014-05-11 Disinvestment policy and the public funding of assisted reproductive technologies: outcomes of deliberative engagements with three key stakeholder groups Hodgetts, Katherine Hiller, Janet E Street, Jackie M Carter, Drew Braunack-Mayer, Annette J Watt, Amber M Moss, John R Elshaug, Adam G BMC Health Serv Res Research Article BACKGROUND: Measures to improve the quality and sustainability of healthcare practice and provision have become a policy concern. In addition, the involvement of stakeholders in health policy decision-making has been advocated, as complex questions arise around the structure of funding arrangements in a context of limited resources. Using a case study of assisted reproductive technologies (ART), deliberative engagements with a range of stakeholder groups were held on the topic of how best to structure the distribution of Australian public funding in this domain. METHODS: Deliberative engagements were carried out with groups of ART consumers, clinicians and community members. The forums were informed by a systematic review of ART treatment safety and effectiveness (focusing, in particular, on maternal age and number of treatment cycles), as well as by international policy comparisons, and ethical and cost analyses. Forum discussions were transcribed and subject to thematic analysis. RESULTS: Each forum demonstrated stakeholders’ capacity to understand concepts of choice under resource scarcity and disinvestment, and to countenance options for ART funding not always aligned with their interests. Deliberations in each engagement identified concerns around ‘equity’ and ‘patient responsibility’, culminating in a broad preference for (potential) ART subsidy restrictions to be based upon individual factors rather than maternal age or number of treatment cycles. Community participants were open to restrictions based upon measures of body mass index (BMI) and smoking status, while consumers and clinicians saw support to improve these factors as part of an ART treatment program, as distinct from a funding criterion. All groups advocated continued patient co-payments, with measures in place to provide treatment access to those unable to pay (namely, equity of access). CONCLUSIONS: Deliberations yielded qualitative, socially-negotiated evidence required to inform ethical, accountable policy decisions in the specific area of ART and health care more broadly. Notably, reductionist, deterministic characterizations of stakeholder ‘self-interest’ proved unfounded as each group sought to prioritise universal values (in particular, ‘equity’ and ‘responsibility’) over specific, within-group concerns. Our results - from an emotive case study in ART - highlight that evidence-informed disinvestment decision-making is feasible, and potentially less controversial than often presumed. BioMed Central 2014-05-05 /pmc/articles/PMC4016640/ /pubmed/24885716 http://dx.doi.org/10.1186/1472-6963-14-204 Text en Copyright © 2014 Hodgetts et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.
spellingShingle Research Article
Hodgetts, Katherine
Hiller, Janet E
Street, Jackie M
Carter, Drew
Braunack-Mayer, Annette J
Watt, Amber M
Moss, John R
Elshaug, Adam G
Disinvestment policy and the public funding of assisted reproductive technologies: outcomes of deliberative engagements with three key stakeholder groups
title Disinvestment policy and the public funding of assisted reproductive technologies: outcomes of deliberative engagements with three key stakeholder groups
title_full Disinvestment policy and the public funding of assisted reproductive technologies: outcomes of deliberative engagements with three key stakeholder groups
title_fullStr Disinvestment policy and the public funding of assisted reproductive technologies: outcomes of deliberative engagements with three key stakeholder groups
title_full_unstemmed Disinvestment policy and the public funding of assisted reproductive technologies: outcomes of deliberative engagements with three key stakeholder groups
title_short Disinvestment policy and the public funding of assisted reproductive technologies: outcomes of deliberative engagements with three key stakeholder groups
title_sort disinvestment policy and the public funding of assisted reproductive technologies: outcomes of deliberative engagements with three key stakeholder groups
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4016640/
https://www.ncbi.nlm.nih.gov/pubmed/24885716
http://dx.doi.org/10.1186/1472-6963-14-204
work_keys_str_mv AT hodgettskatherine disinvestmentpolicyandthepublicfundingofassistedreproductivetechnologiesoutcomesofdeliberativeengagementswiththreekeystakeholdergroups
AT hillerjanete disinvestmentpolicyandthepublicfundingofassistedreproductivetechnologiesoutcomesofdeliberativeengagementswiththreekeystakeholdergroups
AT streetjackiem disinvestmentpolicyandthepublicfundingofassistedreproductivetechnologiesoutcomesofdeliberativeengagementswiththreekeystakeholdergroups
AT carterdrew disinvestmentpolicyandthepublicfundingofassistedreproductivetechnologiesoutcomesofdeliberativeengagementswiththreekeystakeholdergroups
AT braunackmayerannettej disinvestmentpolicyandthepublicfundingofassistedreproductivetechnologiesoutcomesofdeliberativeengagementswiththreekeystakeholdergroups
AT wattamberm disinvestmentpolicyandthepublicfundingofassistedreproductivetechnologiesoutcomesofdeliberativeengagementswiththreekeystakeholdergroups
AT mossjohnr disinvestmentpolicyandthepublicfundingofassistedreproductivetechnologiesoutcomesofdeliberativeengagementswiththreekeystakeholdergroups
AT elshaugadamg disinvestmentpolicyandthepublicfundingofassistedreproductivetechnologiesoutcomesofdeliberativeengagementswiththreekeystakeholdergroups